(Z)-5-Fluoro-3-(4-(1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl)benzylidene)indolin-2-one

ID: ALA4877074

PubChem CID: 149872691

Max Phase: Preclinical

Molecular Formula: C23H14F2N4O

Molecular Weight: 400.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1Nc2ccc(F)cc2/C1=C/c1ccc(-c2cn(-c3cccc(F)c3)nn2)cc1

Standard InChI:  InChI=1S/C23H14F2N4O/c24-16-2-1-3-18(11-16)29-13-22(27-28-29)15-6-4-14(5-7-15)10-20-19-12-17(25)8-9-21(19)26-23(20)30/h1-13H,(H,26,30)/b20-10-

Standard InChI Key:  CBMHJADAQLFESM-JMIUGGIZSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   15.0836  -16.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0825  -17.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7905  -17.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7887  -16.1578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4973  -16.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5022  -17.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2865  -17.6360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7665  -16.9672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2787  -16.3042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5436  -18.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3439  -18.5770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5837  -16.9624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5962  -19.3550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3957  -19.5205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9399  -18.9097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6790  -18.1308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8801  -17.9690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7418  -19.0719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0795  -19.8160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8916  -19.7248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0558  -18.9242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3451  -18.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7972  -18.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4619  -19.0648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2055  -18.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2855  -17.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6160  -17.4377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8751  -17.7774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6927  -16.6241    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.3744  -17.7942    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
 10 11  1  0
  8 12  2  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 18  2  0
 15 18  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 23  1  0
 27 29  1  0
  2 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877074

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKN-45 (2102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 400.39Molecular Weight (Monoisotopic): 400.1136AlogP: 4.71#Rotatable Bonds: 3
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.49CX Basic pKa: CX LogP: 5.29CX LogD: 5.29
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: -1.57

References

1. Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH..  (2021)  Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.,  211  [PMID:33340911] [10.1016/j.ejmech.2020.113083]

Source